L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

Area of Science:

• Cardiovascular Physiology
• Metabolic Disorders

Background:

• Endothelium-dependent vasodilation is compromised in hypercholesterolemia prior to atherosclerosis development.
• Nitric oxide (NO), derived from L-arginine, is a key mediator of vasodilation.

Purpose of the Study:

• To investigate if L-arginine infusion improves endothelium-dependent vasodilation in hypercholesterolemic humans.
• To assess the impact of L-arginine on vascular reactivity in hypercholesterolemia.

Main Methods:

• Vascular reactivity was assessed in forearm resistance vessels of normal and hypercholesterolemic subjects.
• Responses to methacholine (endothelium-dependent) and nitroprusside (endothelium-independent) were measured before and after L-arginine infusion.
• D-arginine was used as a control.

Main Results:

• Hypercholesterolemic subjects exhibited blunted vasodilation to methacholine compared to normal subjects.
• L-arginine administration enhanced methacholine-induced vasodilation in hypercholesterolemic individuals but not in controls.
• Neither L-arginine nor D-arginine affected nitroprusside-induced vasodilation.

Conclusions:

• Endothelium-dependent vasodilation is impaired in hypercholesterolemia.
• Acute L-arginine administration can improve this impairment, potentially by boosting nitric oxide synthesis.
• L-arginine holds promise for managing vascular dysfunction in hypercholesterolemia.